Adenocarcinoma of the Gastroesophageal Junction
📧 Sign up to get email alerts when something new happens for Adenocarcinoma of the Gastroesophageal Junction.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2016-10-12Clinical Trial Update: Epirubicin Hydrochloride, Cisplatin, and Fluorouracil or Capecitabine With or Without Lapatinib Ditosylate as First-Line Therapy in Treating Patients With Stomach Cancer or Gastroesophageal Junction Cancer [Phase 2]
Phase 2 trial of Epirubicin hydrochloride, Cisplatin, and Fluorouracil or Capecitabine with or without Lapatinib for first-line treatment of…
-
CLINICAL_TRIALS trial_result · 2016-05-30Clinical Trial Update: Fluorouracil, Cisplatin, Leucovorin Calcium, and Cetuximab in Treating Patients With Adenocarcinoma of the Stomach or Gastroesophageal Junction [Phase 2]
Phase 2 clinical trial evaluating a regimen of fluorouracil, cisplatin, leucovorin calcium, and cetuximab for adenocarcinoma of the stomach …
-
CLINICAL_TRIALS trial_result · 2016-01-25Clinical Trial Update: Combination Chemotherapy With or Without Vismodegib in Treating Patients With Advanced Stomach Cancer or Gastroesophageal Junction Cancer [Phase 2]
A Phase 2 clinical trial evaluated chemotherapy with or without vismodegib in patients with advanced stomach or gastroesophageal junction ad…
-
CLINICAL_TRIALS trial_result · 2015-10-16Clinical Trial Update: Pralatrexate and Docetaxel in Treating Patients With Stage IV Esophageal or Gastroesophageal Cancer Who Have Failed Platinum-Based Therapy [Phase 2]
This Phase 2 trial investigated the combination of pralatrexate and docetaxel in patients with Stage IV esophageal or gastroesophageal cance…
-
CLINICAL_TRIALS trial_result · 2015-06-29Clinical Trial Update: A Phase I/II Study of Oblimersen Plus Cisplatin and Fluorouracil in Gastric & Esophageal Junction Cancer [Phase 1, Phase 2]
Phase I/II study of oblimersen with cisplatin and fluorouracil in gastric and esophageal cancers; the trial was terminated with results post…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2015-06-03Clinical Trial Update: Bortezomib With or Without Irinotecan in Treating Patients With Cancer of the Gastroesophageal Junction or Stomach [Phase 2]
Phase 2 trial evaluating bortezomib with or without irinotecan in gastroesophageal junction and stomach cancers; study completed with result…
-
CLINICAL_TRIALS trial_result · 2015-05-01Clinical Trial Update: Phase II Study of Oxaliplatin, Irinotecan, and Capecitabine in Advanced Gastric/Gastroesophageal Junction Carcinoma [Phase 2]
Phase II trial evaluating a triplet regimen of oxaliplatin, irinotecan, and capecitabine in advanced gastric and gastroesophageal junction c…
-
CLINICAL_TRIALS trial_result · 2014-11-24Clinical Trial Update: Sorafenib, Docetaxel, and Cisplatin in Treating Patients With Metastatic or Advanced Gastric or Gastroesophageal Junction Cancer [Phase 2]
Phase 2 trial evaluating the combination of sorafenib with docetaxel and cisplatin in patients with metastatic or advanced gastric cancer an…
-
CLINICAL_TRIALS trial_result · 2014-08-19Clinical Trial Update: Panitumumab, Docetaxel, Cisplatin, Radiation Therapy, and Surgery in Treating Patients With Newly Diagnosed, Locally Advanced Esophageal Cancer or Cancer of the Gastroesophageal Junction [Phase 2]
This Phase 2 trial tested a multimodal regimen including panitumumab with docetaxel, cisplatin, radiation therapy, and surgery for newly dia…
-
CLINICAL_TRIALS trial_result · 2014-08-04Clinical Trial Update: Akt Inhibitor MK2206 in Treating Patients With Advanced Gastric or Gastroesophageal Junction Cancer [Phase 2]
Phase 2 trial results for the Akt inhibitor MK-2206 in advanced gastric and gastroesophageal junction cancers have been posted.
-
CLINICAL_TRIALS trial_result · 2014-07-18Clinical Trial Update: Saracatinib in Treating Patients With Locally Advanced or Metastatic Stomach or Gastroesophageal Junction Cancer [Phase 2]
Phase 2 clinical trial update of saracatinib for locally advanced or metastatic stomach/ gastroesophageal junction cancer; results posted af…
-
CLINICAL_TRIALS trial_result · 2014-01-21Clinical Trial Update: Irinotecan Hydrochloride With or Without Alvocidib in Treating Patients With Advanced Stomach or Gastroesophageal Junction Cancer That Cannot Be Removed By Surgery [Phase 2]
A Phase 2 clinical trial evaluated irinotecan hydrochloride with or without alvocidib in advanced stomach and gastroesophageal junction canc…
-
CLINICAL_TRIALS trial_result · 2013-11-25Clinical Trial Update: Pharmacogenomic Study of Docetaxel and Cisplatin, Followed by Docetaxel, Cisplatin and Irradiation. [Phase 2]
A Phase 2 pharmacogenomic study evaluating docetaxel and cisplatin, followed by docetaxel, cisplatin, and irradiation, was terminated.
-
CLINICAL_TRIALS trial_result · 2013-06-04Clinical Trial Update: Erlotinib Hydrochloride in Treating Patients With Advanced Esophageal Cancer or Stomach Cancer [Phase 2]
A Phase II trial evaluating erlotinib hydrochloride in patients with advanced esophageal cancer and gastroesophageal junction cancer has com…
-
CLINICAL_TRIALS trial_result · 2013-06-04Clinical Trial Update: Irinotecan, Cisplatin, and Bevacizumab in Treating Patients With Unresectable or Metastatic Gastric or Gastroesophageal Junction Adenocarcinoma [Phase 2]
This Phase 2 trial evaluated a triplet regimen of irinotecan, cisplatin, and bevacizumab in patients with unresectable or metastatic gastric…
-
CLINICAL_TRIALS trial_result · 2013-02-05Clinical Trial Update: Efficacy and Safety Study of the Combined Modality Therapy in Adenocarcinoma of the Esophago-gastric Junction [Phase 2, Phase 3]
This clinical trial update covers a Phase 2/3 study of a combined modality therapy for adenocarcinoma of the gastroesophageal junction, focu…
-
CLINICAL_TRIALS trial_result · 2012-11-29Clinical Trial Update: Gefitinib in Treating Patients With Esophageal Cancer That is Progressing After Chemotherapy [Phase 3]
A Phase 3 trial evaluating gefitinib in esophageal cancer that progressed after chemotherapy has completed.
-
CLINICAL_TRIALS trial_result · 2012-11-28Clinical Trial Update: Panitumumab, Paclitaxel, Carboplatin and 5FU in the Treatment of Potentially Resectable Gastroesophageal Adenocarcinoma [Phase 2]
Phase 2 clinical trial evaluating panitumumab with paclitaxel, carboplatin and 5-FU in potentially resectable gastroesophageal adenocarcinom…
-
CLINICAL_TRIALS trial_result · 2012-10-02Clinical Trial Update: Impact on Quality of Life in Patients Undergoing Total Gastrectomy or Proximal Gastrectomy for Adenocarcinoma of Esophagogastric Junction [Phase 3]
Phase 3 clinical trial update reporting on quality-of-life outcomes for patients undergoing total gastrectomy or proximal gastrectomy for ad…
-
CLINICAL_TRIALS trial_result · 2011-08-22Clinical Trial Update: Vandetanib, Oxaliplatin, and Docetaxel in Advanced Cancer of the Esophagus or Gastroesophageal Junction [Phase 1]
Phase 1 trial of Vandetanib combined with Oxaliplatin and Docetaxel in advanced cancer of the esophagus or gastroesophageal junction has bee…
-
CLINICAL_TRIALS trial_result · 2009-04-28Clinical Trial Update: Doxorubicin, Cisplatin, 5-Fluorouracil in Patients With Advanced Adenocarcinoma of the Stomach or Esophagus [Phase 2]
Phase 2 trial evaluating doxorubicin, cisplatin, and 5-fluorouracil in patients with advanced adenocarcinoma of the stomach, gastroesophagea…